Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/10/23 16:27 | 2/8/23 | CCCC | Health | BioPrd | Biological Products, (No Diag | Koppikar Utpal | MA | D | P | 32 | 5.60 | 0 | 6 | New | 6 | D | |||||||||||||||
4/12/22 16:05 | 4/12/22 | CCCC | Health | BioPrd | Biological Products, (No Diag | Hirsch Andrew | MA | DO | P,CEO | P | 84 | 8.40 | 0 | 10 | New | 10 | D | ||||||||||||||
10/6/20 21:30 | 10/6/20 | CCCC | Health | BioPrd | Biological Products, (No Diag | McKee William | MA | O | CFO | P | 100 | 19.00 | 0 | 5 | New | 5 | D | ||||||||||||||
10/6/20 21:28 | 10/6/20 | CCCC | Health | BioPrd | Biological Products, (No Diag | Cohen Marc A | MA | DT | P.d | 96 | 19.00 | 0 | 5 | 0 | 4,342 | M | |||||||||||||||
10/6/20 21:26 | 10/6/20 | CCCC | Health | BioPrd | Biological Products, (No Diag | Salter Malcolm | MA | D | P.d | 25 | 19.00 | 0 | 1 | 9 | 16 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |